SC Filed 2021-02-12 Event — SEC 0001839882-21-002097 →

GLAXOSMITHKLINE PLC → Innoviva, Inc. INVA

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 25/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (10.4 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

23 filings by this filer

22 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 10.36

7,265,728 shares short · +6.1% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $15.34M

Point72 Asset Mgmt

Other 13D/G Filings on Innoviva, Inc.

Filed	Form	Filer	Stake	Shares
2025-03-17	SCHEDULE	Sarissa Capital Management LP	4.70%	2,966,022	view →
2025-03-07	SCHEDULE	Sarissa Capital Management LP	8.40%	5,237,161	view →
2021-05-25	SC	Sarissa Capital Management LP	—	—	view →
2021-05-25	SC	GLAXOSMITHKLINE PLC	—	—	view →
2020-12-14	SC	Sarissa Capital Management LP	—	—	view →
2018-04-10	SC	GLAXOSMITHKLINE PLC	—	—	view →

Other Filings by GLAXOSMITHKLINE PLC

Filed	Form	Issuer	Stake	Shares
2023-10-10	SC	Haleon plc HLNCF	—	—	view →
2022-11-14	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2022-09-20	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2022-02-10	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2021-09-16	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2021-09-16	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2021-05-25	SC	Innoviva, Inc. INVA	—	—	view →
2021-04-16	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2021-04-08	SC	Pandion Therapeutics, Inc.	—	—	view →
2020-12-07	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2020-12-07	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2020-10-01	SC	Principia Biopharma Inc.	—	—	view →
2020-06-29	SC	Morphic Holding, Inc.	—	—	view →
2020-06-22	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2020-06-04	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2020-02-27	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2019-04-18	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2018-07-17	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2018-04-10	SC	Innoviva, Inc. INVA	—	—	view →
2018-02-13	SC	HTG MOLECULAR DIAGNOSTICS, INC	—	—	view →

Showing 20 of 22

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →